Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Minerva Respiratory Medicine is Scopus-indexed (Q4, CiteScore 0.2), WoS ESCI. Published by Edizioni Minerva Medica.
Checked against the index lists dated .
ISSN 2724-6493Verify ISSN ↗2784-8477Verify ISSN ↗
Publisher: Edizioni Minerva Medica
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 156 / 165 | 5th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q4, CiteScore 0.2.
Minerva Respiratory Medicine is Q4 in Pulmonary and Respiratory Medicine (rank 156 of 165), by CiteScore 2025.
Minerva Respiratory Medicine is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.2, which places it in quartile Q4 at the 5th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.111, quartile Q4, with an H-index of 10.
Minerva Respiratory Medicine is published by Edizioni Minerva Medica. Its print ISSN is 2724-6493 and its online ISSN is 2784-8477.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Minerva Respiratory Medicine has an h-index of 7 and a 2-year mean of 0.22 citations per paper (OpenAlex). Its Scopus CiteScore is 0.2, quartile Q4. On 2-year citations it ranks #140 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
Minerva Respiratory Medicine published 16 papers in 2025; its busiest recent year was 2022 with 43. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2022–2026), authors are most often from Italy (46.9%), Spain (8.2%) and Türkiye (5.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.